Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityConvertible DebtCurrent AssetsCurrent LeasesCurrent TaxesFinished GoodsGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term Deferred TaxNon-Current AssetsNon-Current Deferred Tax LiabilityOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Raw MaterialsReceivablesReceivables - NetRetained EarningsShareholder's EquityShort-term InvestmentsTotal Current LiabilitiesTotal LiabilitiesTotal Non-Current LiabilitiesTreasury SharesWork In Process
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Lemaitre Vascular (LMAT) Short-term Investments (2017 - 2025)

Historic Short-term Investments for Lemaitre Vascular (LMAT) over the last 9 years, with Q3 2025 value amounting to $317.6 million.

  • Lemaitre Vascular's Short-term Investments rose 20864.73% to $317.6 million in Q3 2025 from the same period last year, while for Sep 2025 it was $317.6 million, marking a year-over-year increase of 20864.73%. This contributed to the annual value of $274.1 million for FY2024, which is 23922.65% up from last year.
  • Latest data reveals that Lemaitre Vascular reported Short-term Investments of $317.6 million as of Q3 2025, which was up 20864.73% from $292.3 million recorded in Q2 2025.
  • In the past 5 years, Lemaitre Vascular's Short-term Investments registered a high of $317.6 million during Q3 2025, and its lowest value of $214000.0 during Q1 2021.
  • In the last 5 years, Lemaitre Vascular's Short-term Investments had a median value of $70.7 million in 2023 and averaged $109.2 million.
  • Over the last 5 years, Lemaitre Vascular's Short-term Investments had its largest YoY gain of 2611682.24% in 2021, and its largest YoY loss of 9891.3% in 2021.
  • Quarter analysis of 5 years shows Lemaitre Vascular's Short-term Investments stood at $56.1 million in 2021, then increased by 13.28% to $63.6 million in 2022, then rose by 27.14% to $80.8 million in 2023, then skyrocketed by 239.23% to $274.1 million in 2024, then grew by 15.85% to $317.6 million in 2025.
  • Its last three reported values are $317.6 million in Q3 2025, $292.3 million for Q2 2025, and $277.2 million during Q1 2025.